Cynthia Sung

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Jenny G. Low, Cynthia Sung, Limin Wijaya et al. · The Lancet Infectious Diseases · 2014 · 240 citations

Phase 1B, Proof-of-concept Trial, Clinical Trials +5

Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model

Abhay P. S. Rathore, Prasad N. Paradkar, Satoru Watanabe et al. · Antiviral Research · 2011 · 158 citations

Celgosivir Treatment Misfolds, Medicine, Pathogenesis +8

Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore

Di Dong, Cynthia Sung, Eric Finkelstein · Neurology · 2012 · 123 citations

Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial

Satoru Watanabe, Abhay P. S. Rathore, Cynthia Sung et al. · Antiviral Research · 2012 · 96 citations

Medicine, Concept Clinical Trial, Antiviral Drug Development +7

SJS/TEN 2019: From science to translation

Wan-Chun Chang, Riichiro Abe, Paul Anderson et al. · Journal of Dermatological Science · 2020 · 74 citations · Full text

Applied Linguistics, Translation Studies, Computer-assisted Translation +6